Gabriel Pedroso Viçozzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gabriel Pedroso Viçozzi has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo André Bender
Universidade Federal do Pampa - de - em Farmacêuticas ; do - de - em ; - de
3 shared publications - Letícia Marques Colomé3 shared publications
- Luiz Torres Neto
Analytical and Molecular Laboratorial Center (CLAn), Institute of Chemistry (IQ), Federal University of Rio de Janeiro (UFRJ), Cidade Universitária, Rio de Janeiro 21941-909, RJ, Brazil
2 shared publications - Solange Cristina Garcia
Universidade Federal do Rio Grande do Sul
2 shared publications - Ana Olivia Laurentino
Programa de Pós-graduação em Farmacologia e Terapêutica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
1 shared publication - Bruna Haendchen Sant'ANa
Programa de Pós-graduação em Farmacologia e Terapêutica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
1 shared publication
Latest Publications
- Open Access
- 6 July 2026
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 11 (s.3)
Mineradores Gaúchos Expostos a Silício Urinário: um estudo da nefrotoxicidade
Introdução: A mineração é uma atividade de grande relevância no Brasil, tanto pelo volume de produção quanto pelo número de trabalhadores expostos a agentes ocupacionais de risco, como a sílica cristalina respirável, presente em rochas e poeiras minerais. A inalação crônica dessas partículas pode causar doenças pulmonares graves, como a silicose, e afetar outros órgãos, como os rins, sugerindo possível nefrotoxicidade. Objetivo: Avaliar preliminarmente se há alterações laboratoriais na função renal de mineradores expostos cronicamente à sílica cristalina. Métodos: Aprovado pelo CAAE da UFRGS (nº 53706121.6.1001.5347), o estudo incluiu 13 mineradores expostos à sílica e 13 trabalhadores não expostos. Amostras de sangue e urina foram coletadas para análise laboratorial, incluindo quantificação de dióxido de silício por espectrometria de emissão óptica de plasma indutivamente acoplado (ICP-OES). Foram avaliados biomarcadores de função renal, como creatinina sérica e microalbuminúria urinária, utilizando analisador bioquímico semi-automático (BS-120 Mindray). Os resultados foram comparados entre os grupos e com valores de referência. Resultados e Conclusões: Mineradores expostos à sílica apresentaram aumento significativo de microalbuminúria urinária (corrigida por g/creatinina) e creatinina sérica, embora abaixo dos valores de referência, sugerindo danos glomerulares precoces. Participantes com alterações bioquímicas relacionadas a doenças metabólicas (ex.: hemoglobina glicada, dados não mostrados) foram excluídos. Observou-se também redução significativa do silício urinário nos expostos, levantando hipóteses sobre possível absorção direta da sílica em nanoescala ou alteração nos mecanismos de excreção renal, considerando a lacuna no conhecimento sobre a toxicodinâmica da sílica cristalina em tecidos além do pulmão. Vale destacar que alimentos comuns na dieta também contêm silício (queijos, aveia, água mineral), o que pode interferir na avaliação. Conclui-se que a exposição ocupacional crônica à sílica cristalina pode contribuir para alterações renais, com potencial papel nefrotóxico. Também que estes são dados preliminares e que o número de mineradores expostos deve ser aumentado para comprovar estas hipóteses.
- 6 July 2026
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 11 (s.3)
Open AccessMineradores Gaúchos Expostos a Silício Urinário: um estudo da nefrotoxicidade
Introdução: A mineração é uma atividade de grande relevância no Brasil, tanto pelo volume de produção quanto pelo número de trabalhadores expostos a agentes ocupacionais de risco, como a sílica cristalina respirável, presente em rochas e poeiras minerais. A inalação crônica dessas partículas pode causar doenças pulmonares graves, como a silicose, e afetar outros órgãos, como os rins, sugerindo possível nefrotoxicidade. Objetivo: Avaliar preliminarmente se há alterações laboratoriais na função renal de mineradores expostos cronicamente à sílica cristalina. Métodos: Aprovado pelo CAAE da UFRGS (nº 53706121.6.1001.5347), o estudo incluiu 13 mineradores expostos à sílica e 13 trabalhadores não expostos. Amostras de sangue e urina foram coletadas para análise laboratorial, incluindo quantificação de dióxido de silício por espectrometria de emissão óptica de plasma indutivamente acoplado (ICP-OES). Foram avaliados biomarcadores de função renal, como creatinina sérica e microalbuminúria urinária, utilizando analisador bioquímico semi-automático (BS-120 Mindray). Os resultados foram comparados entre os grupos e com valores de referência. Resultados e Conclusões: Mineradores expostos à sílica apresentaram aumento significativo de microalbuminúria urinária (corrigida por g/creatinina) e creatinina sérica, embora abaixo dos valores de referência, sugerindo danos glomerulares precoces. Participantes com alterações bioquímicas relacionadas a doenças metabólicas (ex.: hemoglobina glicada, dados não mostrados) foram excluídos. Observou-se também redução significativa do silício urinário nos expostos, levantando hipóteses sobre possível absorção direta da sílica em nanoescala ou alteração nos mecanismos de excreção renal, considerando a lacuna no conhecimento sobre a toxicodinâmica da sílica cristalina em tecidos além do pulmão. Vale destacar que alimentos comuns na dieta também contêm silício (queijos, aveia, água mineral), o que pode interferir na avaliação. Conclui-se que a exposição ocupacional crônica à sílica cristalina pode contribuir para alterações renais, com potencial papel nefrotóxico. Também que estes são dados preliminares e que o número de mineradores expostos deve ser aumentado para comprovar estas hipóteses.
- Open Access
- 1 June 2026
- Published by Springer Nature in Amino Acids
- Vol. 58 (1)
Taurine reduces intracellular glucose accumulation in fructose-treated Caenorhabditis elegans
Regulation of glucose homeostasis is a central feature of antidiabetic drugs such as metformin. However, a subset of individuals exhibited limited therapeutic response, highlighting the need for complementary treatment strategies. Taurine, a semi-essential amino acid, has been reported to improve glycemic control in mammalian models, supporting its potential as an adjuvant therapy for metabolic disorders. In this study, we established a fructose-induced metabolic dysfunction model in Caenorhabditis elegans (C. elegans), characterized by increased intracellular glucose accumulation, and evaluated the effects of taurine. A metabolic dysfunction state was induced in L1-stage N2 Bristol worms by exposing them to 500 mM fructose for 48 h. Metformin (25, 50, and 100 µM) was initially used to establish an effective pharmacological control, and the optimal dose (50 µM) was subsequently employed as a positive control to assess the effects of taurine (10, 50, and 100 µM) under fructose-induced conditions. Fructose exposure significantly increased intracellular glucose levels. Metformin reduced intracellular glucose at all concentrations tested and improved survival at the lowest dose, without affecting morphological parameters. Taurine reduced intracellular glucose accumulation only at the highest concentration tested (100 µM), whereas lower concentrations selectively increased survival, indicating dose-dependent and functionally distinct effects on glucose regulation and organismal viability. These findings show that taurine modulates intracellular glucose accumulation and survival in fructose-treated C. elegans. Given the evolutionary conservation of key pathways involved in glucose metabolism, this model provides a simple and reproducible platform to investigate mechanisms of glucose dysregulation and to screen compounds with potential metabolic or antidiabetic activity.
- 1 June 2026
- Published by Springer Nature in Amino Acids
- Vol. 58 (1)
Open AccessTaurine reduces intracellular glucose accumulation in fructose-treated Caenorhabditis elegans
Regulation of glucose homeostasis is a central feature of antidiabetic drugs such as metformin. However, a subset of individuals exhibited limited therapeutic response, highlighting the need for complementary treatment strategies. Taurine, a semi-essential amino acid, has been reported to improve glycemic control in mammalian models, supporting its potential as an adjuvant therapy for metabolic disorders. In this study, we established a fructose-induced metabolic dysfunction model in Caenorhabditis elegans (C. elegans), characterized by increased intracellular glucose accumulation, and evaluated the effects of taurine. A metabolic dysfunction state was induced in L1-stage N2 Bristol worms by exposing them to 500 mM fructose for 48 h. Metformin (25, 50, and 100 µM) was initially used to establish an effective pharmacological control, and the optimal dose (50 µM) was subsequently employed as a positive control to assess the effects of taurine (10, 50, and 100 µM) under fructose-induced conditions. Fructose exposure significantly increased intracellular glucose levels. Metformin reduced intracellular glucose at all concentrations tested and improved survival at the lowest dose, without affecting morphological parameters. Taurine reduced intracellular glucose accumulation only at the highest concentration tested (100 µM), whereas lower concentrations selectively increased survival, indicating dose-dependent and functionally distinct effects on glucose regulation and organismal viability. These findings show that taurine modulates intracellular glucose accumulation and survival in fructose-treated C. elegans. Given the evolutionary conservation of key pathways involved in glucose metabolism, this model provides a simple and reproducible platform to investigate mechanisms of glucose dysregulation and to screen compounds with potential metabolic or antidiabetic activity.
- Open Access
- 19 December 2025
- Published by Universidade Federal do Rio Grande do Sul in Drug Analytical Research
- Vol. 9 (2) , 31-36
Development and validation of analytical HPLC method for quantification of curcumin in soybean oil nanocapsules
This study aimed to develop and validate an analytical methodology for quantifying curcumin in soybean oil nanocapsules. The chromatography separation used a C18 column (Phenomenex, 4.6 x 150mm, 5μm) and a ternary mixture of acetonitrile, acidified water (pH 3.0), and methanol (53:42:5). The flow rate used was 1 mL.min-1, and curcumin in the samples was detected at 425 nm. The chromatographic method proved specific for curcumin quantification and linear (correlation coefficient 0.9998). The limits of detection and quantification for the curcumin were 0.2575 µg.mL-1 and 0.7804 µg.mL-1, indicating the sensitivity of the analytical method. The repeatability and intermediate precision tests showed that the process is accurate (SRD less than 2%). In addition, the accuracy test showed values close to 100% for recovery of the bioactive. Thus, a new analytical method for quantifying curcumin in soybean oil nanocapsules may be used to analyze bioactive content.
- 19 December 2025
- Published by Universidade Federal do Rio Grande do Sul in Drug Analytical Research
- Vol. 9 (2) , 31-36
Open AccessDevelopment and validation of analytical HPLC method for quantification of curcumin in soybean oil nanocapsules
This study aimed to develop and validate an analytical methodology for quantifying curcumin in soybean oil nanocapsules. The chromatography separation used a C18 column (Phenomenex, 4.6 x 150mm, 5μm) and a ternary mixture of acetonitrile, acidified water (pH 3.0), and methanol (53:42:5). The flow rate used was 1 mL.min-1, and curcumin in the samples was detected at 425 nm. The chromatographic method proved specific for curcumin quantification and linear (correlation coefficient 0.9998). The limits of detection and quantification for the curcumin were 0.2575 µg.mL-1 and 0.7804 µg.mL-1, indicating the sensitivity of the analytical method. The repeatability and intermediate precision tests showed that the process is accurate (SRD less than 2%). In addition, the accuracy test showed values close to 100% for recovery of the bioactive. Thus, a new analytical method for quantifying curcumin in soybean oil nanocapsules may be used to analyze bioactive content.
- 3 December 2024
- Published by Brazilian Journal of Analytical Chemistry in Brazilian Journal of Analytical Chemistry
- Vol. 12 (46) , 18-29
Derivative spectrophotometry allows quantitative determination of essential oils in dispersible powders of spray-dried nanocapsules
This study aimed to develop and validate an analytical methodology based on derivative spectrophotometry to determine the true concentration of ginger (ZEO) and rosemary (REO) essential oils in nanocapsule redispersible powder formulations. Second-order derivative spectrophotometry made it possible to nullify the interference of nanocapsule components at 240 and 245 nm wavelengths for ZEO and REO, respectively. The validated method was linear in the range 0.01-0.04 mg mL−1 for ZEO and 0.6-0.96 mg mL−1 for REO. It is also accurate with RSD of 1.82 and 1.44 for ZEO and REO respectively, and shows recovery rates close to 100% in both essential oils when assessing accuracy. The methodology used allowed the determination of the essential oils in the presence of the formulation components, simply and quickly, showing to be an option to be used for quantification of OEs in these nanometric systems.
- 3 December 2024
- Published by Brazilian Journal of Analytical Chemistry in Brazilian Journal of Analytical Chemistry
- Vol. 12 (46) , 18-29
Derivative spectrophotometry allows quantitative determination of essential oils in dispersible powders of spray-dried nanocapsules
This study aimed to develop and validate an analytical methodology based on derivative spectrophotometry to determine the true concentration of ginger (ZEO) and rosemary (REO) essential oils in nanocapsule redispersible powder formulations. Second-order derivative spectrophotometry made it possible to nullify the interference of nanocapsule components at 240 and 245 nm wavelengths for ZEO and REO, respectively. The validated method was linear in the range 0.01-0.04 mg mL−1 for ZEO and 0.6-0.96 mg mL−1 for REO. It is also accurate with RSD of 1.82 and 1.44 for ZEO and REO respectively, and shows recovery rates close to 100% in both essential oils when assessing accuracy. The methodology used allowed the determination of the essential oils in the presence of the formulation components, simply and quickly, showing to be an option to be used for quantification of OEs in these nanometric systems.